研究单位：[1]Second Xiangya Hospital of Central South University[2]Gansu Provincial People's Hospital,Lanzhou,Gansu,China[3]Shenzhen Second People's Hospital,Shenzhen,Guangdong,China[4]Hainan General Hospital,Haikou,Hainan,China,570311[5]the First Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,China[6]The First Affiliated Hospital of Henan University of Science and Technology,Luoyang,Henan,China[7]The Second Xiangya Hospital, Central South University,Changsha,Hunan,China,410000[8]The First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu,China[9]Heji Hospital Affiliated to Changzhi Medical College,Changzhi,Shanxi,China[10]The First Affiliated Hospital of Xinjiang Medical University,Urumqi,Xinjiang,China,830017[11]The First People's Hospital of Yunnan,Kunming,Yunnan,China[12]Zhejiang Provincial People's Hospital,Hangzhou,Zhejiang,China
The aim of the China Diabetes Type 1 Study (CD1S) is to conduct a nationwide type 1 diabetes (T1D) registry study in patients with T1D and in pediatric adolescent patients with diabetes who had an age of onset <= 20 years. CD1S compromises a retrospective study enrolling inpatients hospitalized from Jan 1st, 2016 to Dec 31, 2021, and a prospective study beginning from the year 2022.
